Henry Meds vs Mochi Health

Neither Henry Meds nor Mochi Health has an FDA warning letter on record. On compounded oral semaglutide, Mochi Health costs $1,296 less a year at standing rates: $141 a month against $249 a month at Henry Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Henry Meds / Mochi Health

Henry Meds logo

Henry Meds

5.6/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$110/moFoundayo (orforglipron) pill
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Henry Meds nor Mochi Health pays us. Links to them earn nothing. Scores: Henry Meds 5.6, Mochi Health 7.1. How we are paid

What the record shows

  1. 01

    Neither Henry Meds nor Mochi Health has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded oral semaglutide, Mochi Health costs $1,296 less a year at standing rates: $141 a month against $249 a month at Henry Meds.

  4. 04

    Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Mochi Health lists all 50 states. Henry Meds publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Henry Meds

Mochi Health

Compounded semaglutide injection

$297/mo

$3,564 a year

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection

$349/mo

$4,188 a year

$169/mo

plan terms unclear; not compared

Compounded oral semaglutide

$249/mo

$2,988 a year

$141/moLower

$1,692 a year

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$110/mo

$1,320 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on monthly plans; longer plans are offered for some treatments
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
Subscription fees generally non-refundable; medication is final sale once shipped
No refunds for partly used periods; medication is not refundable once sent to the pharmacy
Early-exit fee
Yes
Not stated

Read off each seller’s own pages. Henry Meds: October 30, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Henry Meds

5.6/10

The record gives Henry Meds no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list

The case for Mochi Health

7.1/10
  • $1,296 a year less on compounded oral semaglutide
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Henry Meds does not price
  • Names no compounding pharmacy
  • Price leaves out medication

Scores

Henry Meds 5.6 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
7.5

Trust & Safety15%

4.0A
vs
B
8.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Henry Meds vs Mochi Health: questions

Neither Henry Meds nor Mochi Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Mochi Health, by $1,296 a year at standing rates. Henry Meds: $249 a month, about $2,988 a year. Mochi Health: $141 a month, about $1,692 a year.
Henry Meds states you can cancel at any time; refunds: subscription fees generally non-refundable; medication is final sale once shipped. Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Neither Henry Meds nor Mochi Health pays us. Links to them earn nothing. Scores: Henry Meds 5.6, Mochi Health 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks